Cargando…

Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)

OBJECTIVE: This study evaluated the effects of testosterone replacement therapy (TRT) on insulin resistance, cardiovascular risk factors, and symptoms in hypogonadal men with type 2 diabetes and/or metabolic syndrome (MetS). RESEARCH DESIGN AND METHODS: The efficacy, safety, and tolerability of a no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, T. Hugh, Arver, Stefan, Behre, Hermann M., Buvat, Jacques, Meuleman, Eric, Moncada, Ignacio, Morales, Antonio Martin, Volterrani, Maurizio, Yellowlees, Ann, Howell, Julian D., Channer, Kevin S.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064036/ https://www.ncbi.nlm.nih.gov/pubmed/21386088 http://dx.doi.org/10.2337/dc10-1233

Ejemplares similares

Response to Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828–837
por: Jones, T. Hugh, et al.
Publicado: (2011)

Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
por: Kim, Se Hwa
Publicado: (2014)

Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
por: Ide, Veerle, et al.
Publicado: (2020)

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel
por: Pexman-Fieth, Claire, et al.
Publicado: (2014)

Cognitive effects of testosterone and finasteride administration in older hypogonadal men
por: Borst, Stephen E, et al.
Publicado: (2014)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
por: de Almeida Ferreira, Maurício, et al.
Publicado: (2022)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
por: Shoskes, Daniel A, et al.
Publicado: (2015)

ODP412 High Frequency of Erythrocytosis in Hypogonadal Men on Testosterone Replacement Therapy
por: Pérez-Luis, Jesús, et al.
Publicado: (2022)

OR25-06 The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men
por: Seung Lee, Hae, et al.
Publicado: (2023)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men
por: Vincenzo, De Sanctis, et al.
Publicado: (2019)

Statin Therapy Is Associated With Lower Total but Not Bioavailable or Free Testosterone in Men With Type 2 Diabetes
por: Stanworth, Roger D., et al.
Publicado: (2009)

The triad of erectile dysfunction, hypogonadism and the metabolic syndrome
por: Shabsigh, R, et al.
Publicado: (2008)

Testosterone Replacement Therapy in Hypogonadal Men and Myocardial Infarction Risk: Systematic Review & Meta-Analysis
por: Lee, Jun Hee, et al.
Publicado: (2021)

Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial
por: Pencina, Karol M., et al.
Publicado: (2023)

Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy
por: Davidiuk, Andrew J., et al.
Publicado: (2016)

The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
por: Shin, Yu Seob, et al.
Publicado: (2019)

Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism
por: Almehmadi, Yousef, et al.
Publicado: (2016)

Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
por: Lunenfeld, Bruno, et al.
Publicado: (2015)

Study protocol to investigate the effects of testosterone therapy as an adjunct to exercise rehabilitation in hypogonadal males with chronic heart failure
por: Saxton, John M, et al.
Publicado: (2006)

Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
por: Dadhich, Pranav, et al.
Publicado: (2017)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

d-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study
por: Nordio, Maurizio, et al.
Publicado: (2021)

Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials
por: GUO, CHANGCHENG, et al.
Publicado: (2016)

The Effect of Testosterone Replacement Therapy on Penile Hemodynamics in Hypogonadal Men With Erectile Dysfunction, Having Veno-Occlusive Dysfunction
por: Efesoy, Ozan, et al.
Publicado: (2018)

Testosterone replacement therapy in insulin‐sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism
por: Fanelli, Giuseppina, et al.
Publicado: (2020)

Predictive factors for efficacy of testosterone replacement therapy for late-onset hypogonadism in Japanese men: a preliminary report
por: Kondoh, Nobuyuki, et al.
Publicado: (2023)

A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men
por: Swerdloff, Ronald S, et al.
Publicado: (2020)

RF34 | PMON263 Study of Testosterone Replacement in Hypogonadal Men With Uncontrolled Type 2 Diabetes – a Randomised Double Blinded Placebo Controlled Trial (STRIDE Study)
por: Mohan Rao, Preethi, et al.
Publicado: (2022)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
por: Shankara Narayana, Nandini, et al.
Publicado: (2021)

Corrigendum for: “A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men”
Publicado: (2020)

SAT-051 Effects of Testosterone Replacement on Glycemic Control and Other Cardiovascular Risk Factors in Hypogonadal Men with Uncontrolled Type 2 Diabetes (Stride Study): Design, Implementation and Baseline Data
por: Rao, Preethi Mohan, et al.
Publicado: (2020)

Hypogonadism in the Aging Male Diagnosis, Potential Benefits, and Risks of Testosterone Replacement Therapy
por: Surampudi, Prasanth N., et al.
Publicado: (2012)

Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
por: Yassin, AA, et al.
Publicado: (2013)

Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism
por: Monroe, Anne K, et al.
Publicado: (2014)

Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis
por: Elliott, Jesse, et al.
Publicado: (2017)

Prostate-Specific Antigen Concentrations in Response to Testosterone Treatment of Severely Hypogonadal Men
por: Sachdev, Saachi, et al.
Publicado: (2020)

Effect of Varicocele and Its Treatment on Testosterone in Hypogonadal Men with Varicocele: Review of the Literature
por: Çayan, Selahittin, et al.
Publicado: (2020)

Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
por: Russo, Vittoria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fv6gvcvn6be9trmmdoecg26c94